Genetic Study of Schizophrenia

StatusCompleted
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

The 50 most recent of 348 record versions are accounted for below. See every version on ClinicalTrials.gov ↗

  1. Publications: 8 to 9
  2. New version filed on ClinicalTrials.gov
  3. 38 versions Re-verified since Mar 7, 2025, no change to tracked fieldsv309-v346
  4. Trial status: Recruiting to Completed
    • Enrollment target: estimated 6150 to confirmed 4914
    v308
  5. 9 versions Re-verified since Oct 6, 2024, no change to tracked fieldsv299-v307
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This large ongoing study at NIMH investigates the neurobiology of schizophrenia by identifying susceptibility genes, evaluating their impact on brain function to better understand how to treat and prevent this illness.
Trial Details
NCT Number NCT00001486
Lead Sponsor National Institute of Mental Health (NIMH)
Collaborators: National Institutes of Health Clinical Center (CC)
Conditions
(from sponsor)		 Schizoaffective Disorder, Schizophrenia
Related terms Delusions, Hallucinations, Psychotic Disorders, Schizophrenia
Enrollment 4,914 participants
Start Date
Updated on ClinicalTrials.gov